Finding 688221 (2022-001)

Significant Deficiency
Requirement
ABL
Questioned Costs
$1
Year
2022
Accepted
2022-11-07
Audit: 98783
Auditor: Forvis LLP

AI Summary

  • Core Issue: The Corporation failed to accurately report lost revenue for 2020 and 2021 due to an oversight in including a Medicaid settlement in financial statements.
  • Impacted Requirements: Compliance with reporting standards under 45 CFR 75.342 and federal assistance guidelines for the COVID-19 Provider Relief Fund.
  • Recommended Follow-Up: Update policies and procedures for federal grant reporting to ensure all financial information is complete and accurate before submission.

Finding Text

U.S. Department of Health and Human Services (HHS) ? Federal Assistance Listing No. 93.498, COVID-19 Provider Relief Fund Criteria or specific requirement ? Reporting (45 CFR 75.342) and Activities Allowed or Unallowed and Allowable Costs/Cost Principles (Public Law 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623) Condition ? The Corporation is required to prepare and submit Provider Relief Fund reports to HHS. These reports are to be prepared using accurate financial information and submitted by the deadline established. Cause ? Actual patient care-related revenue was adjusted for a Medicaid settlement received during the period; however, the internal financial statements did not include the settlement within patient care-related revenue. Effect or potential effect ? Errors were made in reporting lost revenue for 2020 and 2021. Lost revenue was not accurately reported. Questioned costs ? $2,283,962, which represents lost revenue reported in excess of the properly calculated amount. Context ? An error in the calculation of the lost revenue for the quarters reported was identified. Identification as a repeat finding ? N/A Recommendation ? Policies and procedures over federal grant reporting should be modified to ensure reports are prepared using complete and accurate information. Views of responsible officials ? The Corporation?s management and board agree and will continue to review the requirements related to the program for lost revenues and related reporting. The Corporation had excess incremental healthcare expenses to support the $2,283,962 of questioned costs noted above; therefore, the Corporation has no funding required to be returned.

Categories

Questioned Costs Allowable Costs / Cost Principles Reporting

Other Findings in this Audit

  • 111779 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Covid-19 Provider Relief Fund $40.02M
93.461 Covid-19 Testing for the Uninsured $1.21M
93.697 Covid-19 Testing for Rural Health Clinics $247,307
93.155 Covid-19 Rural Health Research Centers $157,605
93.301 Covid-19 Small Rural Hospital Improvement Grant Program $17,095